Search for: "WATSON PHARMA, INC., AND WATSON LABORATORIES, INC." Results 41 - 60 of 82
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Feb 2013, 4:43 pm by Mandour & Associates
Watson Pharmaceuticals Inc. and Impax Laboratories Inc. both sent letters to Purdue in December, informing the company of their plans to make a generic form of the drug. [read post]
10 Mar 2013, 9:59 pm by Patent Docs
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
4 Oct 2015, 9:08 pm by Patent Docs
Watson Laboratories, Inc. 3:15-cv-05723; filed July 22, 2015 in the District Court of New Jersey Infringement of U.S. [read post]
9 Oct 2009, 9:11 am
Watson Pharmaceuticals Inc., Watson Laboratories, Inc. and Watson Pharma Inc. [read post]
18 Dec 2009, 9:59 am by Karen E. Keller
Watson Laboratories, Inc.- Florida, Watson Pharma Inc. and Watson Pharmaceuticals Inc. [read post]
27 Nov 2013, 6:00 am
Actavis, Inc., along with its wholly owned subsidiaries Actavis Pharma and Watson Laboratories, (collectively, "Actavis") are pharmaceutical companies that develop, manufacture, market and distribute generic pharmaceutical products for sale in the United States. [read post]
12 Oct 2010, 8:56 pm by Kelly
(FDA Law Blog) Lyrica (Pregabalin) – US: Pfizer files patent infringement suit against Lupin in response to Para IV certification filing (Patent Docs) Opana (Oxymorphone) – US: Watson reaches settlement with Endo over Opana ER (SmartBrief) OsmoPrep (Sodium biphosphate, Sodium phosphate) – US: Salix Pharma and Novel Labs settle OsmoPrep patent litigation (Patent Docs) Sanctura XR (Trospium) – US: Allergan file patent infringement complaints against Paddock… [read post]
16 Nov 2012, 2:30 am
The defendants in their case include Watson Laboratories Inc., Actavis Elizabeth LLC and Pliva Inc., manufacturers of the generic equivalent of Reglan, as well as Schwartz Pharma. [read post]
17 Jul 2014, 10:58 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun… [read post]
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco… [read post]
30 Jun 2014, 10:28 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun… [read post]
18 Apr 2016, 12:49 pm by Gene Quinn
The FTC’s complaint alleges that Endo engaged in a pay for delay scheme by paying the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
22 Jun 2011, 4:09 am by Marie Louise
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]